PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Drofenine 2 Drug Target BCHE 1,167 1 0.02 -0.71 0.50 0.72
CRG-2 41 Target Target CRG-10 2 1 0.11 -0.70 0.50 0.83
bFGF 9,327 Target Target aFGF 899 448 0.15 -0.69 0.50 0.79
Cancer 1,053,491 Disease Target APO-2L 90 44 0.00 -0.71 0.49 0.58
CEA 17,022 Target Target CA 15-3 898 437 0.11 -0.71 0.49 0.76
Cancer 1,053,491 Disease Target BRAF 4,766 2,231 0.03 -0.73 0.47 0.62
CCL2 3,560 Target Target CCL8 197 92 0.11 -0.72 0.47 0.78
Erbb2 4,536 Target Target ERBB4 994 461 0.22 -0.69 0.46 0.83
Cancer 1,053,491 Disease Target DAPK1 205 94 0.01 -0.74 0.46 0.58
Diabetes 332,602 Disease Target Exendin-4 855 392 0.02 -0.74 0.46 0.63
Schizophrenia 77,034 Disease Target Metabotropic Glutamate Receptor 3 55 25 0.01 -0.74 0.45 0.64
CD4 112,219 Target Target 4-1BB Receptor 20 9 0.01 -0.74 0.45 0.62
4-1BB Receptor 20 Target Target 4-1BB Ligand 135 9 0.17 -0.72 0.45 0.85
Cancer 1,053,491 Disease Target EPHA2 532 239 0.01 -0.74 0.45 0.59
CCL5 2,002 Target Target CXCL4/PF4 9 4 0.03 -0.74 0.44 0.72
CXCL10/IP-10 114 Target Target CXCL4/PF4 9 4 0.12 -0.73 0.44 0.83
Cancer 1,053,491 Disease Target Kallikrein-6 79 35 0.00 -0.75 0.44 0.58
Anxiety 113,510 Disease Target Neuropeptide S Receptor 77 34 0.01 -0.75 0.44 0.63
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Target Antithrombin 13,773 7 0.01 -0.75 0.44 0.67
Carcinoma 433,099 Disease Target CXCL14/BRAK 7 3 0.00 -0.76 0.43 0.58